Teva Pharmaceutical Industries Limited (TEVA) : The money flow analysis of Teva Pharmaceutical Industries Limited (TEVA) indicates a $37.83 million of outflow was on downticks, whereas, the investors on Tuesday gobbled up stocks worth $46.32 million on upticks. The ratio between the upticks and downticks was clearly in favor of the bulls at 1.22 and so was the total money flow at $8.49 million. A solid up-down ratio of 2.11 in block trades indicates that the investors are accumulating the stock on weakness. The bulls lapped up $4.09 million worth of block trades on upticks. Only $1.94 million worth of the stock exchanged hands on downticks. The money flow was $2.15 million in block trades, underlining the interest of the bulls in the stock even when the stock was declining.However, the price action shows that the bears had an upper hand in the stock of Teva Pharmaceutical Industries Limited (TEVA), pushing it down by -0.37% for the day. The stock slid $0.19 and traded at $50.56 during the day. Nonetheless, the stock is -1.92% over the previous weeks close.
Also, BTIG Research maintains its rating on Teva Pharmaceutical Industries Limited (NYSE:TEVA). The global brokerage major maintains a current price target of $75 per share. Analysts at the BTIG Research have a current rating of Buy on the shares. The rating by the firm was issued on August 24, 2016.
Teva Pharmaceutical Industries Limited has lost 4.96% in the last five trading days and dropped 5.08% in the last 4 weeks. Teva Pharmaceutical Industries Limited has dropped 3.83% during the last 3-month period . Year-to-Date the stock performance stands at -21.49%.
Teva Pharmaceutical Industries Limited (NYSE:TEVA): The stock opened at $50.60 on Tuesday but the bulls could not build on the opening and the stock topped out at $50.95 for the day. The stock traded down to $50.38 during the day, due to lack of any buying support eventually closed down at $50.56 with a loss of -0.37% for the day. The stock had closed at $50.75 on the previous day. The total traded volume was 5,867,294 shares.
Teva Pharmaceutical Industries Limited (Teva) is a global pharmaceutical and drug company. The Companys generic products cover almost every major therapeutic area. The Company operates its business in two segments: Generic medicines, which manufactures and sells generic pharmaceutical products in several dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments and creams, and Specialty medicines, which delivers solutions to patients and providers via medicines, devices and services. Its Central Nervous System (CNS) portfolio includes Copaxone, Azilect and Nuvigil. Its main respiratory medicines include ProAir hydrofluoroalkane, QVAR and Duoresp Spiromax. Its oncology portfolio includes Treanda, Trisenox, Granix Synribo, Lonquex, Tevagrastim/Ratiograstim, Myocet, Trisenox and Eporatio. Its womens health portfolio includes ParaGard, Plan B One-Step OTC/Rx (levonorgestrel) and Zoely.